Home » Topics » Regulatory

Regulatory
RSS

FDA approves Duobrii for plaque psoriasis

April 26, 2019

FDA approves Skyrizi for moderate to severe plaque psoriasis

April 24, 2019

FDA approves Balversa for metastatic bladder cancer

April 15, 2019

FDA approves Dovato for treatment-naive HIV-1

April 9, 2019

CE mark for radioenhancer Hensify for locally advanced soft tissue sarcoma

April 8, 2019

Asceniv approved by FDA to treat humoral immunodeficiency disease

April 2, 2019

FDA approves Duaklir for maintenance treatment of COPD

April 1, 2019

Cimzia becomes the first and only FDA-approved treatment for nonradiographic axial spondyloarthritis

March 29, 2019

Foscavir approved in Japan to treat HHV-6 encephalitis

March 27, 2019

AnGes obtains conditional approval in Japan for HGF plasmid in critical limb ischemia

March 27, 2019